Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
17,591,741
-
Share change
-
+310,933
-
Total reported value
-
$5,456,089,468
-
Put/Call ratio
-
120%
-
Price per share
-
$310.08
-
Number of holders
-
556
-
Value change
-
+$99,391,312
-
Number of buys
-
262
-
Number of sells
-
210
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2017
As of 30 Jun 2017,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
556 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,591,741 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, CITIGROUP INC, GOLDMAN SACHS GROUP INC, UBS Group AG, ALLIANCEBERNSTEIN L.P., BNP PARIBAS ARBITRAGE, SA, CHURCHILL MANAGEMENT Corp, JPMORGAN CHASE & CO, and ROYAL BANK OF CANADA.
This page lists
558
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.